SBW Life Sciences Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 79.85 million compared to KRW 725.97 million a year ago. Net income was KRW 1,126.57 million compared to KRW 1,034.49 million a year ago. Basic earnings per share from continuing operations was KRW 6 compared to KRW 7 a year ago. Diluted earnings per share from continuing operations was KRW 6 compared to KRW 7 a year ago. Basic earnings per share was KRW 6 compared to KRW 7 a year ago.
For the nine months, sales was KRW 79.85 million compared to KRW 2,234.79 million a year ago. Net loss was KRW 7,395.36 million compared to KRW 1,994.93 million a year ago. Basic loss per share from continuing operations was KRW 42 compared to KRW 13 a year ago. Diluted loss per share from continuing operations was KRW 42 compared to KRW 13 a year ago. Basic loss per share was KRW 42 compared to KRW 13 a year ago.